Related Experiment Videos

A case of hepatitis C-associated osteosclerosis in an elderly Japanese man

Tokuji Tanaka1, Shogo Oki, Seiji Muro

  • 1Division of Endocrinology and Metabolism, Osaka Red Cross Hospital, Osaka, Japan.

Endocrine Journal
|May 24, 2006
PubMed

Insights

Hepatitis C-Associated Osteosclerosis (HCAO) involves increased bone density and pain. This case study shows treatment improved bone density and reduced pain in an elderly man with HCAO.

Area of Science:

  • Hepatology
  • Bone Metabolism
  • Rheumatology

Background:

  • Hepatitis C-Associated Osteosclerosis (HCAO) is a rare condition characterized by increased bone mass and pain.
  • Only eleven cases have been reported since 1992, highlighting its rarity.

Observation:

  • This report details a 68-year-old Japanese man with HCAO, followed for three years.
  • The patient presented with bone pain and episodic muscular weakness, with a history of blood transfusion and Hepatitis C virus (HCV) seropositivity.
  • Initial findings included elevated serum alkaline phosphatase (ALP), slightly decreased calcium, and normal phosphate levels, with radiographic evidence of increasing bone density.

Findings:

  • Treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) alleviated bone pain.
  • Vitamin D3 and calcium supplementation reduced muscular weakness episodes and normalized serum calcium.
  • Over three years, bone mineral density significantly increased, serum ALP normalized, and bone pain decreased, suggesting good skeletal quality.

Implications:

  • This case demonstrates effective management strategies for HCAO symptoms.
  • The findings suggest that skeletal tissue in HCAO may possess good quality despite increased density.
  • Further research into HCAO pathogenesis and long-term outcomes is warranted.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...